HomeNDC LookupRxCUI directory › RxCUI 2735366

50 ML leucovorin 10 MG/ML Injection [Vykoura] — RxCUI 2735366

RxNorm drug concept · Semantic branded drug
RxCUI 2735366 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2735366
Official name50 ML leucovorin 10 MG/ML Injection [Vykoura]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asVykoura 500 MG per 50 ML Injection; VYKOURA 500 MG in 50 ML Injection
FDA products mapped3
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Leucovorin Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Not exactly — it depends on your situation. If you're receiving high-dose methotrexate, leucovorin's job is to protect your healthy cells from the drug's toxic effects; think of it...
  • Why am I getting leucovorin injections — is it a treatment for my cancer itself?
  • The most common issues — especially when leucovorin is combined with fluorouracil for colorectal cancer — are nausea, vomiting, diarrhea, mouth sores, and fatigue. These can be mor...
  • What side effects should I watch out for?
📖 Read our full Leucovorin Injection guide →

🕸️ Concept Web — How 50 ML leucovorin 10 MG/ML Injection [Vykoura] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 50 ML leucovorin 10 MG/ML Injection [Vykoura] RxCUI 2735366

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Leucovorin 6313
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Vykoura 2735356
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Leucovorin Injection 1803921
    • Leucovorin Injectable Product 1162848
    • Leucovorin Injection [Vykoura] 2735358
    • Vykoura Injectable Product 2735279
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Leucovorin 10 MG/ML [Vykoura] SBDC · 2735357
  • Leucovorin Injection [Vykoura] SBDF · 2735358
  • Vykoura Injectable Product SBDG · 2735279
  • Vykoura BN · 2735356

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 2735366 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
83831-0147-05 1 VIAL, SINGLE-USE in 1 CARTON (83831-147-05) / 5 mL in 1 V... VYKOURA Avyxa Pharma, LLC 2026-03-16
83831-0148-35 1 VIAL, SINGLE-USE in 1 CARTON (83831-148-35) / 35 mL in 1... VYKOURA Avyxa Pharma, LLC 2026-03-16
83831-0149-50 1 VIAL, SINGLE-USE in 1 CARTON (83831-149-50) / 50 mL in 1... VYKOURA Avyxa Pharma, LLC 2026-03-16
Observed labelers: Avyxa Pharma, LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.